Photodamaged Skin Clinical Trial
Official title:
A Randomized, Double-blinded, Split-face, Comparative Study to Evaluate the Synergistic Effects for Improving the Aging Midface When Pairing a Biostimulator With a Skincare Regimen
Verified date | June 2023 |
Source | Galderma R&D |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To assess skin structural change in midface after treatment with a biostimulator using Line-Field Optical Coherence Tomography
Status | Active, not recruiting |
Enrollment | 21 |
Est. completion date | August 31, 2024 |
Est. primary completion date | March 19, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 22 Years and older |
Eligibility | Inclusion Criteria: - Subjects diagnosed with symmetrical, moderate-to-severe cheek wrinkles on each side of the face as assessed via the Galderma Cheek Wrinkles Scale. - Subjects with symmetrical, mild-to-severe photodamage at both sides of the midface. - Subject who in the opinion of the treating investigator would need 2 biostimulator treatments for optimal clinical outcomes. - Ability of giving consent for participation in the study. - Agreement to adhere to the procedures and requirements of the study and to report to the institute on the day(s) and at the time(s) scheduled for the assessments. Exclusion Criteria: - Subjects with asymmetrical severity or unidentical cheek wrinkle score between 2 sides of the cheek. - Asymmetrical severity photodamage score between 2 sides of the midface. - Subjects with a history of allergy or hypersensitivity to any ingredient of the treatment products. - Previous tissue-augmenting therapy, contouring, or revitalization treatment in the face, except lips. - Previous treatment/procedure in the face in the previous 6 months that, in the Investigator's opinion, would interfere with the study injections and/or study assessments or exposed the study subject to undue risk by study participation, or planning to undergo any of these procedures affecting the treatment area at any time during the study. - Subjects with any medical condition that, in the opinion of the Investigator, would make the subject unsuitable for inclusion. |
Country | Name | City | State |
---|---|---|---|
United States | Markowitz Medicals | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Galderma R&D |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Structural change in midface post-treatment with a biostimulator compared to pre-treatment | Percent change in collagen fiber density using Line-Field Confocal Optical Coherence Tomography at defined timepoints compared to baseline. Collagen density is defined as a number of fibers and is measured on each side of the midface. | 6 weeks and 18 weeks after Baseline | |
Secondary | Improvement in clinical grading score compared to pre-treatment | Percent change in skin parameters includes photodamage, roughness, radiance at defined timepoints compared to re-treatment. Each parameter is assessed by the Investigator on each side of the face using a 10-point Modified Griffiths' scale where 0 = none and 9 = severe. | Baseline, at 6 weeks, 12 weeks, and 18 weeks after Baseline | |
Secondary | Subject satisfaction using a self-assessment questionnaire | Survey where subjects are asked about their satisfaction with treatment outcome on each half of their face. A 5-point subject satisfaction questionnaire with the following responses: strongly agree, agree, neither agree nor disagree, disagree, strongly disagree. | Baseline, at 6 weeks, 12 weeks, and 18 weeks after Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03573076 -
Treatment of Photodamaged Skin of the décolleté
|
Phase 4 | |
Suspended |
NCT03963102 -
Duration of Ameluz Application in Acral Actinic Keratoses Response
|
Phase 4 | |
Completed |
NCT01283464 -
Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles
|
Phase 2 | |
Active, not recruiting |
NCT06170346 -
Effect of Topical Agents With Various Antioxidant Containts on Photodamage Skin Induced
|
Phase 2 | |
Completed |
NCT02736760 -
Daylight-PDT With MAL for AK and Photodamaged Skin
|
Phase 4 | |
Active, not recruiting |
NCT05456334 -
New Treatments for Actinic Keratoses of the Scalp
|
N/A | |
Completed |
NCT05423873 -
A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging
|
N/A | |
Completed |
NCT03095872 -
Comparison of the Effect of Vaseline and Bepanthen® "Wund- Und Heilsalbe" on the Wound Healing Following Laser Therapy
|
Phase 3 | |
Not yet recruiting |
NCT05908825 -
Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults
|
N/A | |
Recruiting |
NCT04523961 -
Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face
|
Phase 2/Phase 3 | |
Completed |
NCT01787461 -
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
|
Phase 4 | |
Recruiting |
NCT06351358 -
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
|
N/A | |
Completed |
NCT04065035 -
A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming
|
N/A | |
Active, not recruiting |
NCT04096742 -
Altreno for Chest Rejuvenation
|
Phase 4 | |
Completed |
NCT02693054 -
Safety and Efficacy Study for Various Skin Conditions
|
N/A | |
Terminated |
NCT00375141 -
Long-Pulsed Dye Laser and Intense Pulsed Light for Skin Rejuvenation.
|
N/A |